Correction: Financial Markets-Stocks story

NEW YORK (AP) — In a story September 29, 2020, which included information about Myovant Sciences’ potential prostate cancer drug, The Associated Press erroneously reported that the drug failed to meet multiple goals in a study. The drug failed to meet one of its goals within a broader late-stage study.

Copyright © 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Related Categories:

Business & Finance

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up